Intravenous Sildenafil in the Treatment of Neonates with Persistent Pulmonary Hypertension
To access this article, please choose from the options below
The study sponsor (Pfizer) provided the intravenous sildenafil, financial support for the clinical research nurse and other costs of conducting the study at each site, as well as ongoing site monitoring. The data analysis was performed by the academic authors and reviewed by statisticians who are employees of Pfizer (M.D. and M.O.). The manuscript was prepared by R.H.S., G.B., and J.P.K. No honorarium or other payment was provided to produce the manuscript.
PII: S0022-3476(09)00560-5
doi:10.1016/j.jpeds.2009.06.012
© 2009 Mosby, Inc. All rights reserved.
